INFQ

INFQ remains in a Stage 4 decline with a bearish medium-term bias. Price is trading below falling EMAs and has extended into oversold territory, increasing the risk of a short-term relief bounce. Execution is best deferred, trimming into any bounce toward the 9/21 EMA cluster to preserve execution quality.

• ↑Q1 revenue $9.5M (+14% YoY); 2026 guide at $40M+
• ↑$569M cash & no debt provides multi-year R&D runway
• ↓Q1 GAAP loss rose to $33.6M from $6.9M